CAMPBELL, Calif., October 17, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced a multi-year agreement with global
Learn three key ways that researchers can implement AI to address data challenges, improve patient safety
and outcomes, and accelerate processes.
In our previous post we talked about the potential of and use cases for generative AI within drug research and discovery. Today, we’ll be examining
With a new drug taking 12 years and $2.6 billion, on average, to reach the market, clinical development stakeholders are actively looking for cost-effective ways
September 19, 2023 – Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today introduced Data Quality (DQ) co-pilot, a feature embedded
Over the last 10 years, clinical trial data volume has increased by a factor of three, challenging sponsors and CROs to collect, clean, aggregate, and make sense of all this data.
No matter what your core focus is as a life sciences organization, manual data review is laborious and time-consuming, and vulnerable to human errors. A
CAMPBELL, Calif.–(BUSINESS WIRE)–Saama, a provider of AI-based solutions that accelerate clinical development and commercialization, today announced that it was named a Leader in the “Life
Saama named as a Leader in the “Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2023” by Everest Group. Everest Group’s PEAK
